Lotus Eye Hospital Complete Financial Statements
In FY2025, Lotus Eye Hospital (LOTUSEYE) reported revenue ₹51 Cr, net profit ₹1 Cr and EPS ₹0.36, with a net profit margin of 2.0% and ROE of 1.7%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Lotus Eye Hospital share price screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
LOTUSEYE Revenue, Net Profit & EBITDA — Year-on-Year Growth
LOTUSEYE YoY (March 2024 vs March 2025) — revenue +2.0%, net profit -66.7%, EBITDA -37.5%, expenses +9.5%. Analyse LOTUSEYE shareholder distribution to track promoter, FII and institutional holdings.
LOTUSEYE Income Statement — Revenue, EBITDA & Net Profit
Lotus Eye Hospital revenue ₹51 Cr, EBITDA ₹5 Cr, net profit ₹1 Cr, EPS ₹0.36 (2025) — net profit margin 2.0%. Also explore Lotus Eye Hospital stock price data download to track price trends across different timeframes.
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51 | 50 | 48 | 40 | 33 | 42 | 39 | 39 | 35 | 32 | 30 |
| Expenses | 46 | 42 | 40 | 33 | 29 | 37 | 35 | 34 | 31 | 27 | 28 |
| EBITDA | 5 | 8 | 9 | 7 | 4 | 5 | 4 | 5 | 4 | 5 | 3 |
| Operating Profit Margin % | 7.00% | 14.00% | 16.00% | 15.00% | 11.00% | 9.00% | 8.00% | 11.00% | 10.00% | 13.00% | 7.00% |
| Depreciation | 3 | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 4 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 4 | 6 | 4 | 2 | 2 | 1 | 2 | 0 | 0 | -2 |
| Tax | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 3 | 4 | 3 | 2 | 1 | 1 | 2 | 0 | 0 | -2 |
| Earnings Per Share (₹) | 0.36 | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 | 0.84 | 0.21 | 0.05 | -0.95 |
LOTUSEYE Balance Sheet — Assets, Liabilities & Shareholders' Equity
LOTUSEYE total assets ₹83 Cr, total equity ₹60 Cr, total liabilities ₹ Cr (2026) — ROE 1.7%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 83 | 70 | 67 | 63 | 62 | 59 | 58 | 57 | 58 | 55 | 55 | 56 |
| Current Assets | 11 | 12 | 14 | 15 | 13 | 14 | 11 | 7 | 8 | 7 | 6 | 5 |
| Fixed Assets | 66 | 54 | 49 | 44 | 44 | 41 | 43 | 44 | 43 | 41 | 44 | 47 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 16 | 18 | 19 | 18 | 19 | 15 | 12 | 15 | 13 | 11 | 9 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 13 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 60 | 60 | 59 | 58 | 55 | 53 | 51 | 50 | 51 | 50 | 50 | 49 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves & Surplus | 39 | 39 | 39 | 37 | 34 | 32 | 31 | 29 | 30 | 29 | 29 | 29 |
LOTUSEYE Cash Flow Statement — Operating, Investing & Financing
Lotus Eye Hospital operating cash flow ₹3 Cr, investing ₹-6 Cr, financing ₹-2 Cr, net cash flow ₹-5 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 6 | 4 | 4 | 3 | 5 | 4 | 6 | 3 | 3 | 2 |
| Investing Activities | -6 | -5 | -2 | -4 | 1 | -1 | -4 | -4 | -1 | -1 | -5 |
| Financing Activities | -2 | -3 | -2 | -2 | 0 | 0 | -1 | -2 | 0 | -1 | 2 |
| Net Cash Flow | -5 | -2 | 1 | -1 | 3 | 4 | -1 | 0 | 2 | 2 | 0 |